Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
U's inhaled treprostinil market size?Can you provide more details about apotex's ruxolitinib anda filing?Sumitomo patents for relugolix in mexico?How does aurobindo's clonazepam production affect its therapeutic effectiveness?China's irreplaceable role in the global generic drug api supply chain?
See the DrugPatentWatch profile for tylenol
Tylenol, a popular over-the-counter pain reliever and fever reducer, is indeed available in Italy. The brand is actually owned by Johnson & Johnson, which operates a significant presence in Europe, including Italy. However, it's essential to note that in Italy, the brand name "Tylenol" may not always refer to the exact same formulation found in other countries, including the United States [1]. This is a common practice in the pharmaceutical industry, where identical active ingredients may be marketed under various brand names or formulations tailored to different regions. According to Johnson & Johnson's official website, the company operates in Italy through its subsidiary, Johnson & Johnson S.p.A., which offers Tylenol as well as other branded products, including cold and flu medications [2]. On DrugPatentWatch.com, a reputable online resource for pharmaceutical information, we can find that the patent status of Tylenol (ibuprofen, a non-aspirin pain reliever, sold in Italy) expired, allowing generic versions to be marketed in the country [3]. In light of this information, it is safe to assume that Tylenol is widely available in Italy, albeit possibly under different formulations or names. Sources: [1] https://www.jnj.com/about-jnj/countries-and-latin-america [2] https://www.jnj.com/about-jnj/countries-and-latin-america [3] https://www.drugpatentwatch.com/drug/paracetamol
Other Questions About Tylenol :